Differential impact of genetic deletion of TIGIT or PD-1 on melanoma-specific T-lymphocytes.
Cadiou G, Beauvais T, Marotte L, Lambot S, Deleine C, Vignes C, Gantier M, Hussong M, Rulli S, Jarry A, Simon S, Malissen B, Labarriere N.
Cadiou G, et al. Among authors: labarriere n.
Oncoimmunology. 2024 Jul 8;13(1):2376782. doi: 10.1080/2162402X.2024.2376782. eCollection 2024.
Oncoimmunology. 2024.
PMID: 38983599
Free PMC article.